LoadingLoadingLoadingThe quick read
Latest quote
Net selling: insiders sold $5.9M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $16K to $65K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet selling: insiders sold $5.9M and bought $0 of MDT stock on the open market in the 90 days to Oct 18, 2026, according to SEC Form 4 filings. $5.8M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Martha, Geoffrey (Chairman and CEO), who sold $4.8M. The latest filing was on Oct 16, 2026.
Rep. Kevin Hern (R) sold $15K to $50K on Aug 24, 2026, disclosed 8 days later. Rep. Richard Dean McCormick (R) sold $1K to $15K on Jul 30, 2026, disclosed 15 days later. In total, 2 members disclosed 2 MDT trades with trade dates in the last 180 days, filed a median 12 days after trading.
This summary uses filings available on Oct 18, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
No tracked top-trader positions in MDT right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Sep 1, 2026
Financial period
Q1 FY2027
Adjusted EPS
$1.39 expected
Revenue
$9.54B expected
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jul 31, 2026 | Sep 1, 2026 | $1.45 / $1.39Yahoo Finance | +4.51% beat | $9.76B / $9.54B | +2.21% beat |
| Apr 30, 2026 | Jun 3, 2026 | $1.55 / $1.54Yahoo Finance | +0.56% in line | $9.81B / Unavailable | Unavailable |
| Jan 31, 2026 | Feb 17, 2026 | $1.36 / $1.34Yahoo Finance | +1.86% beat | Unavailable | Unavailable |
| Oct 31, 2025 | Nov 18, 2025 | $1.36 / $1.31Yahoo Finance | +3.49% beat | Unavailable | Unavailable |
| Jul 31, 2025 | Aug 19, 2025 | $1.26 / $1.23Alpha Vantage | +2.44% beat | Unavailable | Unavailable |
| Apr 30, 2025 | May 21, 2025 | $1.62 / $1.58Alpha Vantage | +2.53% beat | Unavailable | Unavailable |
| Jan 31, 2025 | Feb 18, 2025 | $1.39 / $1.36Alpha Vantage | +2.21% beat | Unavailable | Unavailable |
| Oct 31, 2024 | Nov 19, 2024 | $1.26 / $1.25Alpha Vantage | +0.80% in line | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 17, 2026
EPS expected
$1.32 to $1.34
Revenue expected
23 analysts
Last 30 days
Analysts cutting estimates
| USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $8.96B | $9.02B | $9.81B | $9.76B |
| Cost of what it sold | $3.56B | $3.17B | $2.37B | $3.42B |
| Gross profit | $5.41B | $5.85B | $7.44B | $6.34B |
| What it spent | ||||
| Research and development | $754.0M | $722.0M | $671.0M | $771.0M |
| Sales and admin | $2.96B | $2.92B | $3.06B | $3.20B |
| Other operating costs | — | $441.0M | $2.15B | $607.0M |
| Total operating expenses | $3.72B | $4.08B | $5.88B | $4.58B |
| What was left | ||||
| Operating profit | $1.69B | $1.77B | $1.56B | $1.76B |
| Interest on debt | $181.0M | $181.0M | $177.0M | $186.0M |
| Profit before tax | $1.60B | $1.40B | $1.83B | $1.77B |
| Tax | $215.0M | $254.0M | $575.0M | $289.0M |
| Net profit | $1.37B | $1.14B | $1.24B | $1.47B |
| EBITDA | $2.52B | $2.33B | $2.64B | $2.68B |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Price to book forward of Medtronic Plc – BMV:MDT/N
NeutralOct 16Medtronic Named to TIME Best Inventions of 2026 List for Stealth AXiS surgical system and Corsano* multi-parameter wearable
BullishOct 15Officer Michael Marinaro proposes selling 10,420 Medtronic (MDT) shares.
NeutralOct 15Barclays sets USD 165.00 target for Becton Dickinson stock
NeutralOct 15Medtronic Named to TIME Best Inventions of 2026 List for Stealth AXiS™ surgical system and Corsano™* multi-parameter wearable
BullishOct 15Medtronic Named to TIME Best Inventions of 2026 List for Stealth AXiS™ surgical system and Corsano™* multi-parameter wearable
BullishOct 15MiniMed Announces Board of Directors for its Next Chapter as an Independent Company
Leans bullishOct 15Is Cytokinetics (CYTK) Undervalued As New Aficamten Phase 3 Data Supports Expansion?
NeutralOct 1521 macro signals shaping MDT right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
